Skip to main content Skip to search Skip to main navigation

Tests in the New Ph. Eur. Monograph on Cannabis Flower

5 min. reading time | by Sabine Paris
Published in LOGFILE 5/2024

The monograph on Cannabis flower (3028) has been published in Ph. Eur. Supplement 11.5 in January 2024, with an implementation date of 1 July 2024. 
All member states of the European Pharmacopoeia are required to replace their national monographs with this new Ph. Eur. Monograph. 

Today’s feature lists the tests required by the new monograph and provides first-hand background information from the EDQM.


The monograph on Cannabis flower (3028) has been published in Ph. Eur. Supplement 11.5 in January 2024, with an implementation date of 1 July 2024. All member states of the European Pharmacopoeia are required to replace their national monographs with this new Ph. Eur. Monograph.

Existing national monographs have been used in the preparation of this new monograph, e. g. the monographs of Germany, Denmark, the Netherlands and Switzerland.

The Ph. Eur. monograph on Cannabis flower covers the herbal drug used as a raw material for the production of extracts, or prescribed as is, to be taken by patients by inhalation or oral administration (i.e. prescribed to patients as a medicinal product).

The European Directorate for the Quality of Medicines and HealthCare (EDQM) presented key points and background information in a webinar on 14 December 2023.

This feature summarises the necessary tests required by the monograph.

Tests Cannabis
Monograph (3028)

Maximum

Comment/Background Information

Total CBN: sum of
cannabinol (CBN), and cannabinolic acid (CBNA) expressed as CBN

1.0 %

Contents of more than 1.0 % of CBN indicate significant degradation of the herbal drug.

Liquid chromatography (UV detection) with an octadecylsilyl silica gel column is the method of choice.

Foreign Matter

2.0 %

Seeds and leaves longer than 10 mm are considered foreign matter.

Loss on Drying

12.0 %

It is necessary to perform this test at low temperature (40 °C) and under 'medium vacuum' to minimise evaporation of non-water volatiles (e.g. essential oil/terpenes).

Arsenic

0.2 ppm

If the herbal drug is not used as a medicinal product, the same limits as in the general monograph Herbal Drugs (1433) apply.

Otherwise, the listed limits derived from ICH Q3D for Class I elements based on the permissible daily inhalation exposure apply.

Cadmium

1.0 ppm

Lead

5.0 ppm

Mercury

0.1 ppm

Figure 1                 Test of Ph. Eur. Cannabis flower monograph

 

A specification for moulds is not included in the monograph but this is covered in the general chapter on foreign matter (2.8.2) – ‘other foreign elements‘. A risk assesment shall be carried out for the control of moulds. The sampling procedure and the expected appearance of the herbal drug are defined. Mould control is also covered by GACP (Good Agricultural and Collection Practice).

Other applicable tests according to the general monograph Herbal Drugs (1433) are:

Other tests from the
general monograph Herbal Drugs (1433)

Comment/Background Information

Pesticides

If cultivation takes place in a closed environment where contamination with pesticides is not possible, the manufacturer may justify not testing for pesticides by the design and agricultural method of production. This approach must be agreed with the competent authority.

Aflatoxin B1

According to the general chapter Determination of aflatoxin B1 in herbal drugs (2.8.18) herbal drugs must not contain more than 2 µg/kg of aflatoxin B1.

Microbial contamination

If the herbal drug is used as a medicinal product, the limits in Ph. Eur. chapters 5.1.8 Microbiological quality of herbal medicinal products for oral use and
extracts used in their preparation
and 5.1.4 Microbiological quality of non-sterile pharmaceutical preparations and substances for pharmaceutical use apply.

Figure 2                 Other test from the monograph Herbal Drugs (1433)

 

Test for other aflatoxins than aflatoxin B1 are not included in the monograph because Cannabis flower does not present a particularly high risk of being affected by fungal infections. Cannabis flos does not have a particularly high sugar content.

A test for total ash is not included in the monograph because mineral contamination of Cannabis flower is expected to be very low.


Sources

Ph. Eur. Monograph on Cannabis flower (3028)

EDQM-Webinar: The new Ph. Eur. Cannabis flower monograph (3028), Thu, Dec 14, 2023


Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de

Dr. Sabine Paris
Dr. Sabine Paris

You may also be interested in the following articles:

How is a QRM process initiated?

How is a QRM process initiated?

You can view the answer here:
Read more
FDA: Updated Pre-RFD Guidance for Combination Products

FDA: Updated Pre-RFD Guidance for Combination Products

The U.S. FDA has released an updated final guidance on preparing a Pre-Request for Designation (Pre-RFD), replacing the previous 2018 version. The revised document provides new recommendations for interacting with the Office of Combination Products (OCP) and clarifies expectations for Pre-RFD submissions.
Read more
EDQM: 9 Virtual Training Modules on Ph. Eur. and CEPs

EDQM: 9 Virtual Training Modules on Ph. Eur. and CEPs

The EDQM has introduced a modular training programme covering chemically defined active substances and medicinal products. It will take place between 1 and 12 December 2025.
Read more
Previous
Next

Related Products

Skip product gallery
GMP Compliance Adviser | Named User Licence | 12M

GMP Compliance Adviser | Named User Licence | 12M

The GMP Compliance Adviser is an online publication that covers all aspects of Good Manufacturing Practice (GMP) in one source.In the GMP Compliance Adviser you’ll find: GMP in Practice This part contains 21 chapters with GMP expert knowledge to base your decisions upon. It provides practical assistance with checklists, templates and SOP examples. It is written by more than 80 authors with hands-on experience directly linked to the industry. The individual chapters describe the different aspects of GMP in clear language. Technical, organizational and procedural aspects are covered.More than 700 checklists, templates and examples of standard operation procedures taken directly out of practice help you in understanding the GMP requirements.GMP RegulationsThese chapters cover the most important GMP regulations from Europe and the United States (CFR and FDA), but also PIC/S, ICH, WHO and many more.  Sample Documents In addition, the GMP Compliance Adviser contains many sample documents and practical examples that you can use.

Ready for dispatch, Delivery time appr. 2-5 workdays (2-3 weeks for christmas goodies)
€1,335.00 net excl. VAT
GMP:KnowHow Pharma Logistics (GDP) | Named User License | 12M

GMP:KnowHow Pharma Logistics (GDP) | Named User License | 12M

Your knowledge base about GDP-compliant handling of your pharmaceutical logistics. It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, adhere precisely to the regulatory requirements. The GMP:KnowHow knowledge portal guides you through the regulatory jungle of the pharmaceutical and logistical supply chain! The knowledge portal gives you an easy-to-understand overview of all the important topics. Using graphics, you can easily navigate through all the areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves you a lot of time on time-consuming searches and research!One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP). Where does GDP begin, where does GMP end? What does GDP-compliant mean? When do I also have to take GMP requirements into account? What permits do I need for certain activities? What requirements do I have to fulfil? What is the current legal basis? How am I covered? What authorizations do I have for my work, e.g. from my employer? Who is responsible — the client or the contractor? And many more What is the difference to the GMP Compliance Adviser? The GMP:KnowHow Pharma Logistics (GDP) is your guideline for Good Distribution Practice. It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients. The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance. In addition, sample documents are available to help you make immediate progress. AuthorSimone Ferrante – now Director Quality at Fisher Clinical Services – was previously Head of Quality Control and Responsible Person according to GDP (VP) for the entire Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

Ready for dispatch, Delivery time appr. 2-5 workdays (2-3 weeks for christmas goodies)
€610.00 net excl. VAT
E-Learning GMP:READY | GMP for Engineers Online Course

E-Learning GMP:READY | GMP for Engineers Online Course

Why are GMP rules important for technicians and engineers? Technicians and engineers play a key role in ensuring compliance with Good Manufacturing Practice (GMP) standards. They are involved in critical activities such as: planning and construction of ventilation systems, maintenance of water treatment plants, calibration of measuring sensors. Therefore, they are jointly responsible for the quality of medicines and must ensure that their work complies with GMP standards.Your advantages: Fast familiarization with GMP topics in approx. 2 hours, time- and location-independent online training, printable personal certificate, 12-month access for initial and follow-up training, automatic updates in case of legal changes, content compliant with Article 7(4) of Directive 2003/94/EC.

Ready for dispatch, Delivery time appr. 2-5 workdays (2-3 weeks for christmas goodies)
€240.00 net excl. VAT
GMP Fundamentals | A Step-by-Step Guide

GMP Fundamentals | A Step-by-Step Guide

This handbook is a practical and easy to read guideline, giving you a quick and comprehensive overview of the complex world of Good Manufacturing Practice (GMP) without the need of previously acquired knowledge. Some topics are: GMP: Purpose and basic pharmaceutical terms Laws, licenses and inspections Personnel: Responsibility and hygiene Standard Operating Procedures (SOP) and documentation Design of rooms and facilities Processing and packaging Quality control and market release Suppliers, storage and logistics (Good Distribution Practice = GDP) Alphabetical index and abbreviations Using practical examples and comparisons to every-day life will help to easy understand GMP regulations.GMP Fundamentals is a helpful guide which facilitates the entry into the GMP world and teaches the necessary basics.

Ready for dispatch, delivery immediately after receipt of payment
€44.90 net excl. VAT